BRCA1 and ovarian neoplasm: Immunohistochemical staining on 214 ovarian tumor patients was performed to investigate the findings, thus demonstrating a gradual decrease or even disappearance of BRCA-1 gene expression in benign-borderline-malignant ovarian tumors (Yousif and Mohammed, 2019).